Iovance Biotherapeutics, Inc. (IOVA)
7.63
-0.46
(-5.69%)
USD |
NASDAQ |
Nov 12, 16:00
7.66
+0.03
(+0.39%)
After-Hours: 07:24
Iovance Biotherapeutics Price to Book Value : 4.343 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 4.343 |
| November 11, 2026 | 4.605 |
| November 10, 2026 | 4.599 |
| November 09, 2026 | 4.650 |
| November 06, 2026 | 4.576 |
| November 05, 2026 | 4.405 |
| November 04, 2026 | 4.952 |
| November 03, 2026 | 5.026 |
| November 02, 2026 | 4.565 |
| October 30, 2026 | 4.827 |
| October 29, 2026 | 5.441 |
| October 28, 2026 | 8.429 |
| October 27, 2026 | 8.298 |
| October 26, 2026 | 7.843 |
| October 23, 2026 | 8.020 |
| October 22, 2026 | 8.048 |
| October 21, 2026 | 8.321 |
| October 20, 2026 | 8.458 |
| October 19, 2026 | 8.088 |
| October 16, 2026 | 7.752 |
| October 15, 2026 | 8.378 |
| October 14, 2026 | 8.088 |
| October 13, 2026 | 8.253 |
| October 12, 2026 | 8.287 |
| October 09, 2026 | 8.321 |
| Date | Value |
|---|---|
| October 08, 2026 | 7.576 |
| October 07, 2026 | 7.351 |
| October 06, 2026 | 7.376 |
| October 05, 2026 | 8.054 |
| October 02, 2026 | 8.091 |
| October 01, 2026 | 8.099 |
| September 30, 2026 | 8.435 |
| September 29, 2026 | 8.893 |
| September 28, 2026 | 6.763 |
| September 25, 2026 | 6.770 |
| September 24, 2026 | 6.646 |
| September 23, 2026 | 6.271 |
| September 22, 2026 | 6.548 |
| September 21, 2026 | 6.271 |
| September 18, 2026 | 6.308 |
| September 17, 2026 | 6.166 |
| September 16, 2026 | 6.074 |
| September 15, 2026 | 5.760 |
| September 14, 2026 | 5.699 |
| September 11, 2026 | 5.293 |
| September 10, 2026 | 5.010 |
| September 09, 2026 | 5.188 |
| September 08, 2026 | 5.354 |
| September 04, 2026 | 5.410 |
| September 03, 2026 | 5.354 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AVITA Medical, Inc. | -- |
| Halozyme Therapeutics, Inc. | -- |
| CareDx, Inc. | 8.957 |
| Merck & Co., Inc. | 8.075 |
| SELLAS Life Sciences Group, Inc. | 11.78 |
Price to Book Value Related Metrics
| PS Ratio | 8.717 |
| Price | 7.63 |
| Earnings Yield | -6.81% |
| Market Cap | 3.529B |